Literature DB >> 32099974

The Emerging Role of Mitophagy in Kidney Diseases.

Divya Bhatia1, Mary E Choi1.   

Abstract

Mitochondria fulfill the high metabolic energy demands of the kidney and are regularly exposed to oxidative stress causing mitochondrial damage. The selective removal of damaged and dysfunctional mitochondria through a process known as mitophagy is essential in maintaining cellular homeostasis and physiological function. Mitochondrial quality control by mitophagy is particularly crucial for an organ such as the kidney, which is rich in mitochondria. The role of mitophagy in the pathogenesis of kidney diseases has lately gained significant attention. In this review, we summarize the current understanding of the implications of mitophagy during pathological conditions of the kidney, including acute and chronic kidney diseases.

Entities:  

Keywords:  Mitophagy; acute kidney injury; chronic kidney disease; mitochondria; oxidative stress

Year:  2019        PMID: 32099974      PMCID: PMC7041910          DOI: 10.36069/jols/20191203

Source DB:  PubMed          Journal:  J Life Sci (Westlake Village)


  43 in total

Review 1.  Mechanisms of mitophagy: PINK1, Parkin, USP30 and beyond.

Authors:  Baris Bingol; Morgan Sheng
Journal:  Free Radic Biol Med       Date:  2016-04-16       Impact factor: 7.376

2.  Multiphoton imaging reveals differences in mitochondrial function between nephron segments.

Authors:  Andrew M Hall; Robert J Unwin; Nadeene Parker; Michael R Duchen
Journal:  J Am Soc Nephrol       Date:  2009-05-21       Impact factor: 10.121

3.  Mitophagy-dependent macrophage reprogramming protects against kidney fibrosis.

Authors:  Divya Bhatia; Kuei-Pin Chung; Kiichi Nakahira; Edwin Patino; Michelle C Rice; Lisa K Torres; Thangamani Muthukumar; Augustine Mk Choi; Oleh M Akchurin; Mary E Choi
Journal:  JCI Insight       Date:  2019-12-05

4.  The mitochondria-targeted antioxidant MitoQ ameliorated tubular injury mediated by mitophagy in diabetic kidney disease via Nrf2/PINK1.

Authors:  Li Xiao; Xiaoxuan Xu; Fan Zhang; Ming Wang; Yan Xu; Dan Tang; Jiahui Wang; Yan Qin; Yu Liu; Chengyuan Tang; Liyu He; Anna Greka; Zhiguang Zhou; Fuyou Liu; Zheng Dong; Lin Sun
Journal:  Redox Biol       Date:  2016-12-21       Impact factor: 11.799

5.  Alterations in Mitochondrial Oxidative Stress and Mitophagy in Subjects with Prediabetes and Type 2 Diabetes Mellitus.

Authors:  Shipra Bhansali; Anil Bhansali; Rama Walia; Uma Nahar Saikia; Veena Dhawan
Journal:  Front Endocrinol (Lausanne)       Date:  2017-12-15       Impact factor: 5.555

6.  Drp1-dependent mitophagy protects against cisplatin-induced apoptosis of renal tubular epithelial cells by improving mitochondrial function.

Authors:  Chuanyan Zhao; Zhuyun Chen; Jia Qi; Suyan Duan; Zhimin Huang; Chengning Zhang; Lin Wu; Ming Zeng; Bo Zhang; Ningning Wang; Huijuan Mao; Aihua Zhang; Changying Xing; Yanggang Yuan
Journal:  Oncotarget       Date:  2017-03-28

7.  PINK1 Deficiency Ameliorates Cisplatin-Induced Acute Kidney Injury in Rats.

Authors:  Li Zhou; Ling Zhang; Yu Zhang; Xuan Yu; Xiuping Sun; Tao Zhu; Xianglei Li; Wei Liang; Yunlin Han; Chuan Qin
Journal:  Front Physiol       Date:  2019-09-25       Impact factor: 4.566

Review 8.  Dynamics of Dynamin-Related Protein 1 in Alzheimer's Disease and Other Neurodegenerative Diseases.

Authors:  Darryll Oliver; P Hemachandra Reddy
Journal:  Cells       Date:  2019-08-23       Impact factor: 6.600

9.  Clearance of damaged mitochondria via mitophagy is important to the protective effect of ischemic preconditioning in kidneys.

Authors:  Man J Livingston; Jinghong Wang; Jiliang Zhou; Guangyu Wu; Ian G Ganley; Joseph A Hill; Xiao-Ming Yin; Zheng Dong
Journal:  Autophagy       Date:  2019-05-22       Impact factor: 16.016

10.  PINK1/Parkin-mediated mitophagy is activated in cisplatin nephrotoxicity to protect against kidney injury.

Authors:  Ying Wang; Chengyuan Tang; Juan Cai; Guochun Chen; Dongshan Zhang; Zhuohua Zhang; Zheng Dong
Journal:  Cell Death Dis       Date:  2018-11-01       Impact factor: 8.469

View more
  10 in total

1.  Conditional deletion of myeloid-specific mitofusin 2 but not mitofusin 1 promotes kidney fibrosis.

Authors:  Divya Bhatia; Allyson Capili; Kiichi Nakahira; Thangamani Muthukumar; Lisa K Torres; Augustine M K Choi; Mary E Choi
Journal:  Kidney Int       Date:  2022-02-26       Impact factor: 18.998

Review 2.  Mitochondrial dysfunction in kidney injury, inflammation, and disease: Potential therapeutic approaches.

Authors:  Divya Bhatia; Allyson Capili; Mary E Choi
Journal:  Kidney Res Clin Pract       Date:  2020-09-30

Review 3.  Mitochondrial quality control in kidney injury and repair.

Authors:  Chengyuan Tang; Juan Cai; Xiao-Ming Yin; Joel M Weinberg; Manjeri A Venkatachalam; Zheng Dong
Journal:  Nat Rev Nephrol       Date:  2020-11-24       Impact factor: 28.314

Review 4.  Mitochondrial quality control in stroke: From the mechanisms to therapeutic potentials.

Authors:  Heyan Tian; Xiangyu Chen; Jun Liao; Tong Yang; Shaowu Cheng; Zhigang Mei; Jinwen Ge
Journal:  J Cell Mol Med       Date:  2022-01-17       Impact factor: 5.310

Review 5.  The Mitochondrial Kinase PINK1 in Diabetic Kidney Disease.

Authors:  Chunling Huang; Ji Bian; Qinghua Cao; Xin-Ming Chen; Carol A Pollock
Journal:  Int J Mol Sci       Date:  2021-02-03       Impact factor: 5.923

Review 6.  Mitochondrial Redox Signaling and Oxidative Stress in Kidney Diseases.

Authors:  Ana Karina Aranda-Rivera; Alfredo Cruz-Gregorio; Omar Emiliano Aparicio-Trejo; José Pedraza-Chaverri
Journal:  Biomolecules       Date:  2021-08-03

Review 7.  Mitochondrial Regulation of Diabetic Kidney Disease.

Authors:  Daniel L Galvan; Koki Mise; Farhad R Danesh
Journal:  Front Med (Lausanne)       Date:  2021-09-27

Review 8.  Role of Mitochondrial Nucleic Acid Sensing Pathways in Health and Patho-Physiology.

Authors:  Arpita Chowdhury; Steffen Witte; Abhishek Aich
Journal:  Front Cell Dev Biol       Date:  2022-02-11

Review 9.  Research progress on related mechanisms of uric acid activating NLRP3 inflammasome in chronic kidney disease.

Authors:  Miao Wang; Xin Lin; Xiaoming Yang; Yanlang Yang
Journal:  Ren Fail       Date:  2022-12       Impact factor: 2.606

10.  Potential Therapeutic Targets for Cisplatin-Induced Kidney Injury: Lessons from Other Models of AKI and Fibrosis.

Authors:  Sophia Sears; Leah Siskind
Journal:  J Am Soc Nephrol       Date:  2021-05-28       Impact factor: 14.978

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.